Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decision

Heart Rhythm. 2008 Jun;5(6):861-3. doi: 10.1016/j.hrthm.2008.01.024. Epub 2008 Jan 29.

Authors

Rachel Lampert¹, David Cannom

Affiliation

¹ Yale University School of Medicine, Department of Medicine, New Haven, Connecticut, USA. rachel.lampert@yale.edu

PMID: 18534371
DOI: 10.1016/j.hrthm.2008.01.024

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Brugada Syndrome / therapy
Cardiomyopathy, Hypertrophic / therapy*
Death, Sudden, Cardiac / prevention & control
Decision Making
Defibrillators, Implantable*
Humans
Long QT Syndrome / therapy*
Motor Activity*
Risk Assessment
Sports*